How much does liver disease affect the pharmacokinetics of adriamycin?

Eur J Cancer Clin Oncol. 1985 Aug;21(8):893-5. doi: 10.1016/0277-5379(85)90103-8.
No abstract available

MeSH terms

  • Carcinoma, Hepatocellular / metabolism
  • Doxorubicin / metabolism*
  • Humans
  • Kinetics
  • Liver / metabolism
  • Liver Diseases / metabolism*
  • Liver Neoplasms / metabolism

Substances

  • Doxorubicin